RIXFLUGO
LIVE

Serial Number

98382005

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Jan 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

RIXFLUGO Trademark

Serial Number: 98382005 • Registration: 7587150

RIXFLUGO is a trademark filed by GlaxoSmithKline Biologicals SA on January 30, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

January 30, 2024

Registration Date

December 3, 2024

Published for Opposition

October 1, 2024

Goods & Services

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 3, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 27, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 27, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 27, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 27, 2024 CNEA
ASSIGNED TO EXAMINER
Aug 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 29, 2024 NWOS
NEW APPLICATION ENTERED
Jan 30, 2024 NWAP